Target intelligence / Profile preview

Arginine-ornithine antiporter (ArcD) (ArcD)

Target
ArcD
Molecular classification
Transporter, Antiporter
01

Overview

The Arginine-ornithine antiporter (ArcD) is a specialized membrane transport protein that serves as the gateway for the Arginine Deiminase System (ADS) in commensal oral streptococci, including Streptococcus sanguinis and Streptococcus gordonii (Burne & Marquis, 2000). It facilitates the stoichiometric exchange of extracellular L-arginine for intracellular ornithine, ensuring a continuous supply of substrate for intracellular catabolism (Liu et al., 2012). Within the cell, the ADS converts arginine into ammonia, carbon dioxide, and ATP; the resulting ammonia is critical for neutralizing the lactic acid produced by cariogenic bacteria like Streptococcus mutans (Nascimento et al., 2014). By maintaining a neutral pH environment within the dental plaque, ArcD activity helps prevent the demineralization of tooth enamel and promotes a microbial balance favorable to oral health (Griswold et al., 2004). Consequently, this transport system is a key target for prebiotic interventions, such as arginine-supplemented oral care products, which aim to enhance the alkali-generating capacity of the oral microbiome to combat dental caries (Nascimento et al., 2014).

Other names
Arginine:ornithine exchangerADS-associated arginine transporterArcD proteinArginine-ornithine exchange protein
02

Mechanism of action

Facilitates the uptake of arginine into commensal oral streptococci to fuel the arginine deiminase system, resulting in ammonia production and plaque pH neutralization.

03

Biological functions

Arginine metabolismpH regulationAcid stress responseATP productionIon homeostasis
04

Disease associations

Dental cariesInfectionOral dysbiosis
05

Safety considerations

Microbiome dysbiosisAmmonia-related mucosal irritation
06

Interacting drugs

L-Arginine

1 more in the full profile.

07

Biomarkers

Salivary ammonia levelsPlaque pHADS activityCommensal-to-pathogen ratio

Beyond the preview

Go deeper on Arginine-ornithine antiporter (ArcD) (ArcD).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Arginine-ornithine antiporter (ArcD) (ArcD).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call